 intraven immunoglobulin therapi membran nephropathi efficaci safeti preliminari result efficaci high-dos intraven human igg patient biopsy-confirm idiopath membran nephropathi imgn patient normal renal function creatinin clearanc bsa group patient moder renal insuffici creatinin clearanc bsa group puls dose igg g/kg BW consecut day boli time interv period bolu week respond patient end trial new renal biopsi group patient complet remiss proteinuria daili proteinuria wherea patient partial remiss proteinuria g/day group patient complet remiss partial remiss patient variat proteinuria respond patient clinic biolog find nephrot syndrom signific increas creatinin clearanc control biopsi end trial immunofluoresc immunodeposit recoveri glomerular lesion light microscopi conclus igg therapi benefit patient imgn random clinic trial preliminari report